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Abstract
Background: Vitamin D is under scrutiny as a potential regulator of the development of respiratory diseases
characterised by chronic lung inflammation, including asthma and chronic obstructive pulmonary disease. It has
anti-inflammatory effects; however, knowledge around the relationship between dietary vitamin D, inflammation
and the microbiome in the lungs is limited. In our previous studies, we observed more inflammatory cells in the
bronchoalveolar lavage fluid and increased bacterial load in the lungs of vitamin D-deficient male mice with allergic
airway disease, suggesting that vitamin D might modulate the lung microbiome. In the current study, we examined
in more depth the effects of vitamin D deficiency initiated early in life, and subsequent supplementation with
dietary vitamin D on the composition of the lung microbiome and the extent of respiratory inflammation.
Methods: BALB/c dams were fed a vitamin D-supplemented or -deficient diet throughout gestation and lactation,
with offspring continued on this diet post-natally. Some initially deficient offspring were fed a supplemented diet
from 8 weeks of age. The lungs of naïve adult male and female offspring were compared prior to the induction of
allergic airway disease. In further experiments, offspring were sensitised and boosted with the experimental
allergen, ovalbumin (OVA), and T helper type 2-skewing adjuvant, aluminium hydroxide, followed by a single
respiratory challenge with OVA.
Results: In mice fed a vitamin D-containing diet throughout life, a sex difference in the lung microbial community
was observed, with increased levels of an Acinetobacter operational taxonomic unit (OTU) in female lungs compared to
male lungs. This effect was not observed in vitamin D-deficient mice or initially deficient mice supplemented with
vitamin D from early adulthood. In addition, serum 25-hydroxyvitamin D levels inversely correlated with total bacterial
OTUs, and Pseudomonas OTUs in the lungs. Increased levels of the antimicrobial murine ß-defensin-2 were detected in
the bronchoalveolar lavage fluid of male and female mice fed a vitamin D-containing diet. The induction of OVA-
induced allergic airway disease itself had a profound affect on the OTUs identified in the lung microbiome, which was
accompanied by substantially more respiratory inflammation than that induced by vitamin D deficiency alone.
Conclusion: These data support the notion that maintaining sufficient vitamin D is necessary for optimal lung health,
and that vitamin D may modulate the lung microbiome in a sex-specific fashion. Furthermore, our data suggest that
the magnitude of the pro-inflammatory and microbiome-modifying effects of vitamin D deficiency were substantially
less than that of allergic airway disease, and that there is an important interplay between respiratory inflammation and
the lung microbiome.
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Background
Vitamin D has been proposed as an important regulator
of both inflammation [1] and the microbiome [2, 3]. In-
deed, it is hypothesised that there is a protective role for
vitamin D in regulating the gut microbiome, which may
shape predisposition for the development of inflamma-
tory autoimmune and allergic diseases [2–4]. Vitamin D
is commonly acquired through skin exposure to ultravio-
let B radiation found in sunlight and through the diet.
Circulating 25-hydroxyvitamin D (25(OH)D) is typically
used as a measure of vitamin D status, although 1,25-
dihydroxyvitamin D (1,25(OH)2D) is the most active
vitamin D metabolite.
Our understanding of the effects of vitamin D on the
microbiome and its associations with reduced tissue in-
flammation is currently limited to the gastrointestinal
tract. Colitis severity and bacterial numbers in the co-
lons of mice were increased during vitamin D deficiency
[5]. Dietary-induced vitamin D deficiency altered the
composition of the fecal microbiome of C57Bl/6 mice,
which had increased relative quantities of Bacteroidetes,
Firmicutes, Actinobacteria, and Gammaproteobacteria [6].
These mice also had increased colonic injury in compari-
son to mice fed a vitamin D-sufficient diet, but exhibited
signs of hypocalcemia [6]. In other studies, the colons of
21-day-old vitamin D-deficient mice were enriched for
Bacteroides/Prevotella colony forming units, although this
difference disappeared with age [7]. CYP27B1−/− mice,
which lack the expression of the 1α-hydroxylase enzyme,
responsible for converting circulating 25(OH)D to active
1,25(OH)2D, had an increased fecal burden of Proteobac-
terium phylum (including Helicobacteraceae species) in a
colitis model [8]. Treatment of CYP27B1−/− mice with
1,25(OH)2D (1.25 μg/100 g diet) suppressed colitis sever-
ity and Helicobacteraceae numbers [8]. Vitamin D supple-
mentation (980 IU vitamin D3/kg per week for 4 weeks) of
16 healthy young adults reduced the relative abundance of
Gammaproteobacteria such as Pseudomonas spp. and
Escherichia/Shigella spp., increasing bacterial richness in
the upper gastrointestinal tract, but not in ileum, colon
nor in stool samples [9]. Changes in Bacteroides spp. were
identified in the stool samples of African American
men (n = 115) with prediabetes and hypovitaminosis D
after weekly supplementation with a vitamin D
analogue (ergocalciferol; 50,000 IU) [10]. Together,
these data suggest that dietary vitamin D can alter the
gut microbiome, reducing the abundance of potentially
pathogenic species with these changes linked to reduced
gastrointestinal inflammation and injury.
Vitamin D may shape the microbiome through a num-
ber of interdependent mechanisms. Firstly, vitamin D
regulates innate immune responses. Vitamin D can in-
duce the expression of antimicrobial peptides and pro-
teins, such as cathelicidins and ß-defensins, which are
produced by monocytes, macrophages and epithelial
cells in the skin and lung [1, 3]. Vitamin D-deficient
mice had reduced colonic expression of the antimicro-
bial protein, angiogenin-4, which was associated with in-
creased bacterial load, and tissue inflammation [5]. Such
antimicrobials may directly kill microbiota or be in-
volved in activating innate immune processes such as
autophagy in macrophages, promoting the ingestion of
microbes into phagolysosomes for neutralization [11].
Vitamin D may promote tolerant adaptive immune
responses by modulating the gut microbiome. As
highlighted above, there is evidence linking the modi-
fied gut microbiome and increased gut inflammation
of CYP27B1−/− mice, with fewer tolerogenic CD103+
dendritic cell in lamina propria [8]. These are cells
responsible for shaping the regulatory T cell reper-
toire of the gut [12]. Ongoing presentation of bacter-
ial antigens by dendritic cells may be required for
tolerance towards gut microbes, with an essential role
for tolerogenic dendritic cells and T cells to limit in-
flammation [13, 14]. Finally, vitamin D may up-keep
epithelial integrity. Colonic epithelial cells from
CYP27B1−/− mice expressed reduced levels of the
cell-to-cell adhesion protein, E-cadherin [8]. Assa et
al. [6] demonstrated that vitamin D-deficient mice
had reduced colonic epithelial barrier function, with
increased permeability that associated with increased
proinflammatory cytokine expression, signs of colitis
and relative quantities of Bacteroidetes, Firmicutes,
Actinobacteria and Gammaproteobacteria in the in-
testinal microbiome.
In healthy human lungs, the bronchial tree holds ap-
proximately 2000 distinct bacterial genomes per cm2
[15]. There are diverse microbial communities, with
Bacteroidetes, Proteobacteria and Firmicutes the mostly
commonly identified at the phylum level [16]. Similarly,
the healthy mouse lung microbiome is dominated by
species of these phyla and also Actinobacteria and
Cyanobacteria [17]. The lung microbiome changes from
infancy through to adulthood, with the ratio of Bacteroi-
detes:Firmicutes/Gammproteobacteria increasing with
age in specific-pathogen-free mice [18]. However, dys-
regulation of the microbiome of the lungs and associated
tissues could contribute towards respiratory inflammation.
Indeed, microbial communities shift in the respiratory
tract during respiratory disease [15, 19–23]. Hilty et al.
[15] demonstrated that pathogenic proteobacteria were
more common in bronchial brushings of the left upper
lung lobe of adult asthmatics (n = 11) or patients with
chronic obstructive pulmonary disease (COPD) (n = 5)
than controls (n = 8), with similar findings in the bron-
choalveolar lavage fluid (BALF) of asthmatic children
(n = 13). Lung tissue samples from patients with COPD
(n = 8) had increased bacteria of the Lactobacillus
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genus with bacterial communities distinct to healthy
controls (n = 8), smokers without COPD (n = 8) or pa-
tients with cystic fibrosis (n = 8) [20]. Lactobacillus,
Pseudomonas, and Rickettsia species were enriched in
endobronchial brush samples from patients with
chronic persistent asthma (n = 39) in comparison to
healthy controls (n = 19) [21]. The bronchial brushings
of patients with severe asthma (n = 30) were enriched
with Actinobacteria and a member of the Klebsiella
genus in comparison to healthy controls (n = 8) and
mild-to-moderate asthmatics (n = 41) [22]. Together,
these findings suggest that pathogenic bacteria are
more common in the lungs and associated respiratory
tissue of patients with respiratory disease, which may
vary depending on the site examined.
Animal models offer the opportunity of dissecting
various factors that change the lung microbiome to initi-
ate and/or exacerbate inflammatory or allergic lung dis-
eases. The effect of vitamin D deficiency on the lung
microbiome has not been specifically investigated in
vivo. We previously observed that inflammatory cell
numbers in the BALF of vitamin D-deficient male mice
with allergic airway disease were associated with in-
creased bacterial load in the lungs [24]. Low levels of cir-
culating 25(OH)D were associated with increased
numbers of eosinophils and neutrophils in BALF in male
mice with allergic airway disease [24]. Increased levels of
BALF inflammation and microbial load in the lungs of
initially vitamin D-deficient mice were reversed by diet-
ary vitamin D supplementation [24]. In the current
study, we hypothesised that vitamin D deficiency would
alter the lung microbiome of naïve mice, potentially con-
tributing towards increased respiratory inflammation,
prior to the initiation of allergic airway disease.
Methods
Mice and diets
All experiments were performed according to the ethical
guidelines of the National Health and Medical Re-
search Council of Australia and with approval from the
Telethon Kids Institute Animal Ethics Committee
(AEC#238). Mice were purchased from the Animal Re-
sources Centre, Western Australia. Mice were main-
tained under specific-pathogen-free conditions. Female
3 week-old BALB/c mice were fed semi-pure diets,
which were either supplemented with vitamin D3
(2,280 IU vitamin D3/kg, SF05-34, Specialty Feeds, Perth,
Western Australia) or not (0 IU vitamin D3/kg, SF05-033,
Specialty Feeds) as previously described [24, 25]. From
8 weeks of age, female mice were mated with male BALB/
c mice for up to 2 weeks. These male mice were fed stand-
ard mouse chow until breeding (Specialty Feeds, contain-
ing 2,000 IU vitamin D3/kg). Litter sizes from dams fed
either diet were a mean of 5 pups per litter, with equal
proportions of females and males. Offspring born were
fed the vitamin D-replete or -deficient diets for the rest
of the experiment, except in experiments when initially
vitamin D-deficient mice were switched to a vitamin D-
replete diet at 8 weeks of age (Fig. 1). Experiments were
performed over a 12-month period between November
2011 and November 2012.
Measurement of serum and BALF levels of
25-hydroxyvitamin D (25(OH)D)
Serum and BALF 25(OH)D levels were measured using
IDS EIA ELISA kits (Immunodiagnostic Systems Ltd,
Fountain Hills, AZ) as described by the manufacturer
(limit of detection was 5–7 nmol/L).
Fig. 1 The dietary intake of mice in each treatment. In (A), female BALB/c mice (dams) were fed vitamin D-containing (VitD+) or vitamin D-null
(VitD−) diets from 3 weeks of age and used to produce offspring. A subgroup of the vitamin D-deficient offspring was fed a vitamin D-supplemented
diet from 8 weeks of age (VitD−/+)
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Determining bacterial loads in lung samples
Following the BALF procedure (see below), the left lobe
of each lung was minced using a sterile scalpel blade. A
2 mm3 sample of the lung was snap-frozen in liquid ni-
trogen. DNA was extracted from lung samples using the
DNeasy Blood and Tissue DNA extraction kit as de-
scribed by the manufacturer (Qiagen). Universal 16S
rRNA primers (F primer = 5′-TCCTACGGGAGGCAG
CAG T-3′; R primer = 5′-GGACTACCAGGGTATCTA
ATCCTGTT-3′ [26]) were used to detect bacteria in
DNA samples using the Power SYBR Green PCR Master
Mix as described by the manufacturer (Applied Biosys-
tems, Calsbad, USA). These ‘universal primers’ have
broad specificity to detect conserved regions of 16S
rDNA from 34 bacterial species encompassing most bac-
terial groups [26]. An 18S rRNA endogenous control in-
cluding a FAM-MGB probe was used as the internal
control for this assay using conditions described by the
manufacturer (Applied Biosystems).
Characterising the bacterial lung microbiome
To profile the microbial community of the lungs, we
amplified the variable region V3-V4 of the 16S rRNA
gene as previously reported [17], with modifications,
using the primer pair of 341 F and 806R. The PCR mix
was composed of 5 μl 5x Phusion buffer HF (7.5 mM
MgCl2, Finnzymes, Finland), 0.5 μl 10 mM dNTPs,
1.25 μl 10 μM of each primer, 0.25 μl DNA polymerase
(Hotstart Phusion 540 L, 1 unit/μl Finnzymes) and 3.5 μl
template. The PCR program started with 98 °C (2 min),
followed by 35 cycles of denaturation at 98 °C (5 s), an-
nealing at 55 °C (30 s) and strand elongation at 60 °C
(60 s). The PCR was finalised by a single elongation step
at 72 °C for 5 min and than cooled to 4 °C. The size of
the PCR product was evaluated using gel electrophor-
esis. The fragment was then excised and purified using
the Montage Gel Extraction Kit (Merck Millipore) with
negative controls also excised at the position of the ex-
pected fragment size. Adaptors were added to the ampli-
cons in a second PCR run under the same conditions as
PCR I with a reduced cycle number of 15. The se-
quences were generated with GS FLX Titanium (454 Life
Sciences, Roche). Two sequencing runs were performed,
with the machine cleaned between runs (using standard
protocols) and the second run then proceeding, with
each run containing samples from the ‘naïve’ and ‘OVA-
induced allergic airway disease’ datasets. The 1,475,452
reads were trimmed for low quality (minimal quality
score = 25) using the Qiime pipeline version 1.5.0 [27].
Only sequences with a minimal length of 200 bp were
considered, the sequences were denoised using the
Ampliconnoise algorithm [28]. Chimeras were removed
using the Uchime algorithm [29]. Operational taxonomic
units (OTUs) were picked de novo from quality-checked
reads and clustered at 97 % sequence similarity using
Uclust. Taxonomy was assigned using the RDP classifier
(version 2.2) method and Greengenes as reference data-
base [30]. After data treatment, 280,699 reads from the
‘naïve dataset’, and 330,733 reads from the ‘OVA-allergic
airway disease’ dataset, were used for down stream ana-
lysis. To adjust for differences in sequencing depth be-
tween samples the OTUs were normalised using the
cumulative sum-scaling method available in the meta-
genomeSeq Bioconductor package [31].
Bronchoalveolar lavage fluid for assessment of
ß-defensin-2 (mBD2)
A total of 1 ml BALF was collected for each mouse as
described previously [32]. Levels of mBD2 in BALF were
detected using an ELISA kit and method supplied by
USCN Life Science Inc (Wuhan, China).
Sensitisation and challenge of mice with ovalbumin
Ovalbumin (OVA) (Sigma Chemical Company, St Louis,
MO, USA) was mixed with an aluminium hydroxide sus-
pension (Alum, Serva, Heidelberg, Germany). This
OVA/Alum solution was diluted in 0.9 % saline to sensi-
tise and boost mice intraperitoneally (200 μl) with 1 μg
OVA and 0.2 mg Alum as previously described, with
mice sensitised at 12 weeks of age and boosted at 14 days
of age [24]. For respiratory challenge, mice were placed
in a Perspex box and inhaled a 1 % OVA-in-saline
(1 mg/ml) aerosol delivered using an ultrasonic nebuliser
(UltraNebs, DeVilbiss, Somerset, PA, USA) for 30 min.
This was performed once, 7 days after the OVA/Alum
boost. Lungs and BALF was obtained 24 h after the
aerosol challenge.
Bronchoalveolar lavage fluid for assessment of
inflammatory cells
BALF cells (5 × 105) were spun onto glass slides using a
cytocentrifuge and differential counts of inflammatory
cells performed after staining cells with the DIFF-Quik
Stain Set 64851 (Lab Aids, Narrabeen, NSW, Australia)
as per the manufacturer’s instructions. At least 300 cells
were counted for each sample from ≥3 independent
fields of view (x100).
Measurement of circulating immune cells
Blood was obtained from mice and immediately added
to K2EDTA-coated Microtainer tubes (BD, Franklin
Lakes, NJ) to prevent clotting. The proportions of circu-
lating neutrophils and monocytes within the white blood
cell population was determined using the ADVIA® 120
Haematology System (Siemens Healthcare Diagnostics
Inc, Tarrytown, NY).
Roggenbuck et al. Respiratory Research  (2016) 17:116 Page 4 of 18
Statistical analyses
Data were compared using one-way ANOVA or an un-
paired two-way student’s t test or correlated (Spearman’s
rank correlation) using the Prism 5 for Mac OS X statis-
tical analysis program. Differences were considered sig-
nificant with a p-value <0.05. We used the non-
parametric Kruskal-Wallis test (p < 0.05) to test for sig-
nificant differences in OTU abundance. Treatment ef-
fects on the complex microbial communities in the lung
were observed by applying the vegdist function (part of
the R vegan package) on the raw metagenomeSeq nor-
malised OTU abundance table to generate the Bray-
Curtis dissimilarity between samples.
The lungs of specific-pathogen-free mice contain little
microbial DNA, and as recently described for micro-
biome studies [33] are of high risk of contamination by
bacterial DNA present in molecular biology reagents
used for high throughput sequencing. These can espe-
cially contribute towards incorrect interpretations of
cluster analyses. However, simply removing OTUs
from the abundance table might introduce bias by
potentially removing ‘real’ OTUs present in the sam-
ple (e.g. Escherichia spp.). Therefore, the entire clus-
ter analysis that was based on the metagenomeSeq
normalised OTU table was performed twice; first
with, and then without 126 OTUs detected in the
blank reagents and listed in the OTU table that con-
tained afterwards 5,635 OTUs for downstream ana-
lysis. Most (96 %) of the contaminating OTUs were
taxonomically assigned to the halophilic marine genus
Halomonas. The rest were Shewanella, Delftia and
Stenotrophomonas. Unless stated differently we used
the cleaned microbial OTU table describing the lung
microbiome according to [34].
The Bray-Curtis dissimilarity test takes microbial di-
versity and relative abundance into account. Grouping
of samples was visualised by using ordination apply-
ing non-metric multidimensional scaling (NMDS)
generated in the R vegan package [35]. Microbial
clustering was further evaluated with the analysis of
similarity (ANOSIM), which takes the ranked dissimi-
larities (Bray-Curtis) of samples belonging to the same
treatment group and compares it to the distance of
samples of a different treatment [36]. The closer the
ANOSIM generated R-value was to 1, the larger the
variation between microbial treatments, whereas 0 in-
dicates no difference. The results were than tested for
significance by 999 permutations with a 5 % signifi-
cance level. Individual variation of selected microbes
was displayed with the Euclidean distance in a one-
sided dendrogram (Heatmap) based on the log-
transformed metagenomeSeq normalised OTU counts.
The percentage of each OTU was relative to the
number of OTUs for each sample.
Results
Dietary vitamin D increased circulating but not BALF
25(OH)D levels
Circulating serum levels of 25(OH)D were measured in
8-week old offspring born to vitamin D-replete and -de-
ficient dams (Fig. 2a). Serum 25(OH)D levels were <20
or ≥50 nmol.L−1 in offspring fed a vitamin D-deficient
or -replete diet, respectively. When vitamin D-deficient
offspring were fed a vitamin D-containing diet for four
weeks, their serum 25(OH)D increased to levels equiva-
lent to mice fed a vitamin D-containing diet throughout
the experiment (Fig. 2a). BALF 25(OH)D levels were
low, although greater than the detection limit of the
ELISA and not affected by dietary vitamin D (Fig. 2b).
The effects of dietary vitamin D on bacterial loads in the
lungs of naive mice
There was a trend similar to our previously published
findings (24) for increased bacterial load in the lungs of
vitamin D-deficient male mice, although this was not
statistically significant (One-way ANOVA, F = 1.481, p =
0.245; Fig. 3). Bacterial load was quantified using a PCR
with 16S rRNA primers capable of amplifying DNA of
most bacterial species.
Dietary vitamin D had a sex-specific effect on the lung
microbiome of naive mice
We used high-throughput sequencing to determine
how vitamin D might affect the composition of bacteria
in the lung microbiome. After data treatment (see
methods) there was an average read distribution of
4,803 sequences per naïve animal. We first evaluated if
dietary vitamin D had a significant impact on the mi-
crobial composition enumerating the dissimilarity of
the OTUs. As shown in NMDS plots, there was no
clustering by diet (Fig. 4a), sex (Fig. 4b), or the combin-
ation of both (Fig. 4c). We then evaluated the relative
abundance of OTUs with 23–112 OTUs identified/
mouse (Fig. 5). Neither dietary vitamin D nor sex sig-
nificantly affected bacterial diversity in the lungs as de-
fined by the relative number (Fig. 5, Kruskal-Wallis
Test, p > 0.05) of OTUs. In Fig. 6, a heat map was used
to show the most frequent OTUs identified from the
lungs of male mice. There was very little effect of diet-
ary vitamin D on the relative proportion of each OTU
(Fig. 6), with similar findings in female mice (data not
shown), and little difference in bacterial variation be-
tween treatments identified using ANOSIM analysis,
except in mice fed a vitamin D-containing diet through-
out the experiment (Table 1).
We observed a significant separation (NMDS cluster)
between female and male mice that were fed the vitamin
D-supplemented diet throughout the experiment (Fig. 7).
This difference was attributed to increased representation
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of an Acinetobacter OTU in female mice, which varied
significantly between the mice (Wilcoxon Rank Sum
test, p = 0.02), together with a single low-abundant
OTU that could only be annotated as bacteria. Reduced
carriage of the Acinetobacter OTU was observed in
male mice (2/10 mice; ≤5 % of sequences in the ob-
served sequences; mean = 0.7 %), compared to female
mice (7/10 mice; ≤40 % of sequences in the observed
sequences; mean = 7.0 %) fed a vitamin D-containing
diet throughout the experiment.
Antimicrobial levels in the lungs were enhanced by
dietary vitamin D in both male and female mice
In both male and female mice, dietary vitamin D in-
creased ß-defensin-2 (mBD2) protein levels in BALF,
with the effects of early-life vitamin D-deficiency re-
versed by dietary vitamin D (Fig. 8a). There was no ef-
fect of dietary vitamin D on serum mBD2 levels
(Fig. 8b). Levels of mBD2 were significantly greater in
serum than BALF. These results suggest that the sex-
dependent effects of vitamin D on Acinetobacter in the
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supplemented diet from 8 weeks of age (VitD−to VitD+). Bacterial DNA levels were determined in the lungs of naïve mice using a PCR with universal
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Fig. 2 Vitamin D deficiency reduced serum 25(OH)D levels but had no effect on BALF 25(OH)D levels. Female BALB/c mice (dams) were fed
vitamin D-containing (VitD+) or vitamin D-null (VitD-) diets from 3 weeks of age and used to produce offspring. A subgroup of the vitamin D-
deficient offspring was fed a vitamin D-supplemented diet from 8 weeks of age (VitD−to vitD+). In (a), serum 25(OH)D levels in offspring at 8 and
12 weeks of age (mean ± SEM for ≥5 mice per group). In (b) BALF 25(OH)D levels in offspring at 12 weeks of age (mean ± SEM for ≥3 mice per
group, the broken line indicates the level of detection (LOD) for 25(OH)D; 7 pg/ml). (*p < 0.05)
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lungs were not due to differences in the expression of
mBD2 as dietary vitamin D increased levels to a similar
degree in the BALF of male and female mice.
Serum 25(OH)D levels inversely correlated with the most
prominent OTU of Pseudomonas in the lung
In a separate analysis, we identified an inverse correl-
ation between serum 25(OH)D levels and the total num-
ber of OTUs (Fig. 9, Spearman’s rho = −0.592, p = 0.001).
When each sex was considered separately, some evi-
dence for an inverse correlation was observed between
total OTUs in the lungs and serum 25(OH)D levels in
females (Spearman’s rho = −0.642, p = 0.052) but not
males (Spearman’s rho = 0.463, p = 0.238). When exam-
ining individual OTUs in the lungs, there was a strong
negative correlation between 25(OH)D levels in serum
and an unspecified Pseudomonas OTU (Spearman’s
rho = −0.556, p = 0.016), with a marginal evidence ob-
served in females (Spearman’s rho = −0.611, p = 0.081)
but not males (Spearman’s rho = −0.343, p = 0.366).
Some evidence for a negative correlation was observed
between serum 25(OH)D and all Pseudomonas OTUs
(Spearman’s rho = −0.429, p = 0.07). However, there was
no evidence of a relationship between total OTUs or
the unspecified Pseudomonas OTUs in the lung and
mBD2 levels in BALF (total OTUs; Spearman’s rho =
0.109, p = 0.429; Pseudomonas OTU Spearman’s rho =
0.202, p = 0.138 for BALF) or serum (total OTUs;
Spearman’s rho = 0.114, p = 0.673, Pseudomonas OTU
Spearman’s rho = 0.114, p = 0.673).
The lung microbiomes of naïve mice, and, ovalbumin
(OVA)-sensitised and -challenged mice clustered separately
We hypothesised that allergic sensitisation and challenge
with OVA (to induce allergic airway disease) would sig-
nificantly change the microbiota composition of the
lungs. The relative effects of the induction of OVA-
induced allergic airway versus that of vitamin D defi-
ciency (alone) on the lung microbiome are unknown. To
better understand the magnitude of the observed effect
of dietary vitamin D on the lung microbiome, we com-
pared its capacity to regulate the lung microbiome to
the effects of the induction of allergic airway disease.
Mice were intraperitoneally sensitised and boosted with
a
b
c
Fig. 4 The lung microbiomes of vitamin D-replete and -deficient
naïve mice were similar. Female BALB/c mice (dams) were fed vitamin
D-containing (+) or vitamin D-null (−) diets from 3 weeks of age and
used to produce offspring. A subgroup of the vitamin D-deficient
offspring was fed a vitamin D-supplemented diet from 8 weeks of
age (−/+). Non-metric multidimensional scaling (NMDS) plots
depict the dissimilarity of the detected operational taxonomic units
(OTUs) from the lungs, with results shown for clustering by (a) diet,
(b) sex, or (c) all (M = male, F = female; n = 9-10/treatment)
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ovalbumin (OVA) (1 μg) and Alum hydroxide suspension
(Alum, adjuvant, 0.2 mg) at 12 and 14 weeks of age (re-
spectively), which was followed by a respiratory chal-
lenge at 15 weeks of age with aerosolised OVA-in-saline
(1 mg/ml) [24]. Lungs were sampled 24 h after the chal-
lenge. We compared the overall microbial community
from the lungs of the naïve mice characterised above (n
= 58; 4,803 sequences per naïve mouse) with the lungs
of mice with OVA-induced allergic airway disease (n =
68; 4,469 sequences per mouse). As shown in Fig. 10a,
the lung samples of naïve mice and mice with allergic
airway disease clustered significantly apart, which was
confirmed using a compositional analysis to compare
the difference in numbers of observed bacterial OTUs
(Bray-Curtis, R = 0.334, p = 0.001). A NMDS analysis
confirmed that observed differences were not induced
by performing two sequencing runs (data not shown).
Bacterial diversity was not affected with the mean
number of OTUs for naïve mice or mice with allergic
airway disease (naïve, 138 + 5.1; allergic airway disease,
128 + 5.4; mean + SEM, p = 0.132), respectively.
The lung microbiome was significantly altered by allergic
airway disease
The strength of the difference between the lung micro-
biomes of naïve mice, and, mice with allergic airway
disease was quantified by ANOSIM. A significant dif-
ference was identified (Table 2). As for naïve mice
(Fig. 7), a significant separation (NMDS cluster) was
observed between female and male mice that were fed
the vitamin D-supplemented diet throughout the ex-
periment with OVA-induced allergic airway disease
(Fig. 10b; Table 3 for ANOSIM bacterial variance).
There was a significant effect of allergic airway disease
on the relative proportion of OTUs detected in mice.
The most abundant OTUs detected, which each
accounted for >1 % of the sequences after
normalization, are shown for the naïve mice, or, mice
with allergic airway disease in Fig. 11a. Proportions of
the environmental microbial group GNO2 (Naïve,
mean = 9.5 %; OVA, mean = 0.0 %) and an unassigned
bacterial OTU (Naïve, mean = 1.1 %; OVA, mean = 0.0 %)
were reduced in mice with OVA-induced allergic airway
disease, while Acinetobacter (Naïve, mean = 1.29 %; OVA,
mean = 1.8 %), Chloroplast (Naïve, mean = 0.1 %, OVA,
mean = 5.0), Comamonadaceae (Naïve, mean = 0.1 %;
OVA, mean = 4.0.%), Cyanobacteria (Naive, mean = 0.1 %;
OVA, mean = 1.0 %) Staphylococcus (Naïve, mean = 0.5 %;
OVA, mean = 1.2 %), Micrococcaceae (Naïve, mean =
0.1 %; OVA, mean = 1.8 %) and Verrucomicrobiaceae
(Naïve, mean = 0.1 %; OVA, mean = 7.6 %) OTUs, and an
OTU assigned to Peptostreptococcaceae (Naïve, mean =
1.0 %; OVA, mean = 1.5 %) were increased by the induc-
tion of allergic airway disease. The Acinetobacter OTU
significantly increased in the OVA samples was not the
same Acinetobacter OTU identified as responsible for
largely driving the difference between male and female
mice fed a vitamin D-containing diet throughout the ex-
periment. There was no significant difference in the num-
ber of any Pseudomonas OTUs detected in the lungs of
naïve mice, or, mice with allergic airway disease. Together,
these results suggest that the effects of allergic airway dis-
ease on the lung microbiome of mice far exceeded those
of vitamin D deficiency.
Even though OVA-induced allergic airway disease sub-
stantially altered the lung microbiome, the sex-specific
effect on the abundance of Acinetobacter OTUs was still
apparent in mice fed exclusively a vitamin D-containing
diet (Table 3). Acinetobacter OTUs were more frequent
in OVA-induced allergic airway disease than naïve mice
(Fig. 11b). There were a further 11 OTUs varied in their
frequency when the lung microbiomes of female and
male mice with OVA-induced allergic airway disease
were compared. However, these were present at a very
low frequency (<0.01 % of the total normalised se-
quences). There was no effect of OVA-induced allergic
Fig. 5 Dietary vitamin D did not affect the diversity of the lung
microbiome. Female BALB/c mice (dams) were fed vitamin D-
containing (+) or vitamin D-null (−) diets from 3 weeks of age and
used to produce male (M) and female (F) offspring. A subgroup of
the vitamin D-deficient offspring was fed a vitamin D-supplemented
diet from 8 weeks of age (−/+). Shown are the number of operational
taxonomic units (OTUs) observed at a sequencing depth of 1,200 per
animal, with no significant effect of sex or vitamin D. Data is shown
with the median as a blue line, the first or third quartiles as the upper
and lower boxes (respectively) and the upper and lower whiskers show
the 1.5 times of the interquartile distance and minimum and maximum
data (n = 9–10/treatment, with an outlier denoted as a circle)
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airway disease on the proportions of the dominant Aci-
netobacter OTU in female mice; however, induction of
OVA-induced allergic airway disease increased the pro-
portions of this OTU in male mice. For example, for
male mice fed the vitamin D-containing diet throughout
the experiment, the percentage of this OTU increased
from 0.69 + 0.51 (mean + SEM) in naïve mice to 4.7 +
1.5 in mice with OVA-induced allergic airway disease
(*p < 0.05, n = 10–13 mice/treatment). There was no
significant correlation between the number of Acineto-
bacter OTUs and 25(OH)D or mBD2 levels in BALF or
serum (Spearman p > 0.05, data not shown).
OVA-induced allergic airway disease had a substantially
greater effect on inflammatory cells in BALF than vitamin D
deficiency
The effects of vitamin D deficiency and the induction of
OVA-induced allergic airway disease on numbers of
neutrophils and macrophages/monocytes in the BALF or
blood were then compared. Substantially increased
BALF neutrophil numbers were observed in both male
(Fig. 12a) and female (Fig. 12e) mice with OVA-induced
allergic airway disease as expected; however, there was
only a marginal effect of vitamin D deficiency. There
was also a significant increase in neutrophil numbers in
the blood of female mice with OVA-induced allergic air-
way disease, with no effect of vitamin D deficiency
(Fig. 12f ). Neither treatment significantly modulated
macrophage levels in BALF (Fig. 12b, f ), nor monocytes
levels in blood (Fig. 12d, h). These data suggest that
there is an important interplay between respiratory in-
flammation and the lung microbiome.
Discussion
We observed modest effects of dietary vitamin D on the
bacterial composition of the lung microbiome. Serum
25(OH)D levels inversely correlated with the number of
OTUs detected, and more specifically the presence of an
Fig. 6 The abundance of bacterial operational taxonomic units was minimally affected by vitamin D deficiency. Female BALB/c mice (dams) were
fed vitamin D-containing (+) or vitamin D-null (−) diets from 3 weeks of age and used to produce offspring. A subgroup of the vitamin D-
deficient offspring was fed a vitamin D-supplemented diet from 8 weeks of age (−/+). Shown is a heat map of the of operational taxonomic units
(OTUs) significantly detected in the lungs of male (M) naïve offspring. OTU counts were log-transformed; with red denoting increased frequency
of a given OTU, and dark blue no occurrence (n = 9-10/treatment)
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unidentified Pseudomonas OTU in the lungs of naïve
mice. These results suggest that vitamin D sufficiency
limited the number of respiratory pathobionts (like
Pseudomonas) rather than increasing the number of pro-
tective commensals in the lungs. We also observed a sex
difference in mice fed the vitamin D-containing diet
throughout the experiment, with differences observed
largely limited to a single Acintobacter OTU. The induc-
tion of allergic airway disease altered the lung micro-
biome composition to a degree that far exceeded any of
the more subtle effects of vitamin D deficiency. More
external environmental microbes, such as Cyanobacteria
and Chloroplast, were detected in mice with allergic air-
ways disease as well as OTUs previously identified in the
lung microbiome, such as Staphylococcus, Peptostrepto-
coccaceae and Acinetobacter. BALF neutrophil numbers
were increased in mice of both sexes by ~10-fold with
the induction of OVA-induced allergic airway disease,
while the effects of vitamin D deficiency on these cell
numbers in BALF were modest.
There were sex-specific differences in the lung micro-
biomes of mice fed a vitamin D-containing diet through-
out the experiment. The Acinetobacter OTU, which
accounted these effects, was distinct from the Acineto-
bacter OTU modulated by OVA-induced allergic airway
disease. The nature of the sex-specific effect of vitamin
D on the Acinetobacter OTUs differed, depending on
whether mice were naïve or had OVA-induced allergic
airway disease. We have previously shown sex-specific
clustering of the lung microbiome in a different mouse
strain (C57Bl/6) using denaturing gradient gel electro-
phoresis [37]. Acinetobacter may be a common com-
mensal of human [38] and mouse lungs [17]. This genus
may colonise the lungs early in life and has been linked
to protection from allergy [39–41]. The switching of the
direction of the sex-specific effects may reflect differ-
ences in the severity of OVA-induced allergic airway dis-
ease in male and female mice that are regulated by
vitamin D, as previously observed [24]. The sex-specific
effects on the lung microbiome were not reproduced by
supplementing initially deficient mice with vitamin D,
supporting the hypothesis that colonization with Acine-
tobacter species in the lungs occurs early in life.
As we have previously observed, 25(OH)D levels were
reduced in male mice as compared to female mice fed a
vitamin D-containing diet (see also [24, 25, 42, 43]). This
observation is explained by increased renal expression of
24-hydroxylase (CYP24A1), the enzyme responsible for
breaking down active 1,25(OH)2D, in male mice [42].
Hormones influence other effects of vitamin D, with re-
ports of functional synergies between 1,25(OH)2D and
17-β-estradiol in T cells [44, 45], and differential regula-
tion of 1,25(OH)2D-modulated pathways by testosterone
in males and females [45, 46]. Testosterone increased
Foxp3 (regulatory gene) expression in T cells from
women, but not men [46] and 1,25(OH)2D more po-
tently induced CD4 + CD25 + Foxp3+ (regulatory) T cells
from PBMCs of female than male subjects [45], although
we observed similar reductions in TReg cell percentages
in the skin-draining lymph nodes of vitamin D-deficient
male and female mice [47]. These effects of estrogen and
Table 1 Comparison of the lung microbiome within groups
with analysis of similarity (ANOSIM) examining the effects of sex
or dietary vitamin D in naïve mice
Factor Groups compared ANOSIM R p-value
Sex F+ vs M+ 0.151 0.017*
F- vs M− −0.065 0.822
F−/+ vs M−/+ −0.033 0.659
Vitamin D M+ vs M− −0.044 0.811
M+ vs M−/+ 0.049 0.151
M−/+ vs M− 0.008 0.379
F+ vs F− −0.051 0.681
F+ vs F−/+ 0.013 0.406
F−/+ vs F− −0.047 0.738
*Significant clustering, p < 0.05
F = Female
M =Male
(+) = fed vitamin D-supplemented diet throughout life
(−) = fed vitamin D-null diet throughout life
(−/+) = fed vitamin D-null diet until 8 weeks of age and then vitamin
D-supplemented diet
Fig. 7 The lung microbiomes of vitamin D-replete and -deficient naïve
mice were similar. Female BALB/c mice (dams) were fed vitamin D-
containing (+) or vitamin D-null (−) diets from 3 weeks of age and
used to produce offspring. A subgroup of the vitamin D-deficient
offspring was fed a vitamin D-supplemented diet from 8 weeks of age
(−/+). Non-metric multidimensional scaling (NMDS) plots depict the
dissimilarity of the detected operational taxonomic units (OTUs) from
the lungs, with results shown for clustering for mice fed the
vitamin D+ diet only. (M = male, F = female; n = 9–10/treatment)
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testosterone on immune cell function suggest that fe-
males may be more resilient to the effects of vitamin D
deficiency than males.
The inverse relationship between lung Pseudomonas
and serum 25(OH)D could be related to increased levels
of mBD2 in BALF of vitamin D-sufficient mice. mBD2 is
a member of the defensin family of peptides, which have
well-established killing effects on Gram-negative bacteria
like Pseudomonas. mBD2 exhibits significant protein se-
quence homology with human ß-defensins 1 and 2 [48]
and is expressed by a variety of epithelial cells (including
tracheal) as well some immune cells (reviewed in [49]).
mBD2 expression is induced during infection with
Gram-negative bacteria, their products (e.g. lipopolysac-
charide), and various proinflammatory cytokines (e.g.
tumour necrosis factor) [48, 50]. Lipopolysaccharide
may also drive the production of active 1,25(OH)2D
from circulating 25(OH)D, resulting in synthesis of ß-
defensins [51]. mBD2 is an immunoregulatory mol-
ecule, and its expression improves bacterial resistance
by promoting proinflammatory cytokine expression
through activation of toll-like receptor-4 [50]. Using
immunohistochemistry, other researchers have detected
only minimal concentrations of mBD2 in the lungs of
BALB/c mice with OVA-induced allergic airway disease
[52]. In addition, reduced levels of cathelin-related anti-
microbial peptide (the mouse equivalent of cathelicidin)
were detected in mice with OVA-induced allergic air-
way disease in comparison to non-sensitised mice [53].
These findings suggest that OVA-induced allergic airway
disease may reduce the expression of antimicrobials like
mBD2 levels in the lungs.
Regulation of mBD2 by vitamin D may significantly in-
hibit specific bacteria like Pseudomonas. Wu et al. dem-
onstrated that mBD2 was required for host resistance
against corneal infection with Pseudomonas aeruginosa
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Fig. 8 Vitamin D deficiency reduced ß-defensin-2 (mBD2) protein levels in the BALF of naïve mice. Female BALB/c mice (dams) were fed vitamin
D-containing (VitD+) or vitamin D-null (VitD-) diets from 3 weeks of age and used to produce offspring. A subgroup of the vitamin D-deficient
offspring was fed a vitamin D-supplemented diet from 8 weeks of age (VitD− to VitD+). ß-defensin-2 protein levels were determined in the
BALF (a) (n = 10 mice/treatment) and serum (b) (n ≥ 3 mice/treatment) of naïve mice (mean + SEM) (*p < 0.05, the broken line indicates the
level of detection (LOD) for ß-defensin-2; 3 pg/ml)
Fig. 9 Number of operational taxonomic units in lungs inversely
correlated with serum 25(OH)D. Female BALB/c mice (dams) were
fed vitamin D-containing (+) or vitamin D-null (−) diets from 3 weeks
of age and used to produce offspring. A subgroup of the vitamin D-
deficient male and female offspring was fed a vitamin D-supplemented
diet for 4 weeks from 8 weeks of age (−/+). A significant inverse
correlation was observed between the number of operational
taxonomic units (OTUs) in the lungs and circulating 25(OH)D levels
(for n = 18 mice for whom both measures were obtained)
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[49]. These bacteria were more frequently detected in
the sputum of vitamin D-deficient patients with bronch-
iestasis than -replete patients [54]. However, in another
study there was no difference in the incidence of P. aer-
uginosa infection in children with cystic fibrosis that
were vitamin D-deficient or -sufficient (25(OH)D >
30 μg/L) [55]. Active 1,25(OH)2D (10 nM) induced anti-
microbial activity in bronchial epithelial cells against P.
aeruginosa [56]. While we observed a significant inverse
relationship between total OTUs or numbers of an un-
specified Pseudomonas OTU and serum 25(OH)D, there
was no inverse association with mBD2 in BALF. It is likely
that another explanation, such as compromised epithelial
integrity [6, 8], is responsible for the observed inverse rela-
tionship between serum 25(OH)D and lung OTUs.
In addition to Pseudomonas, we identified microbes in
the lungs of our naïve mice that were previously de-
tected in the lungs of humans [57] and other mice [17]
including OTUs of Micrococcus, Staphylococcus, Cupria-
vidus and Streptococcus. The microbiome dataset from
the lung tissue of naive mice (in particular) was very
sparse, with few OTUs found among all lung samples
(~130–140 OTUs/mouse). We obtained lung samples
directly from the thoracic cavity of euthanised specific-
a
b
Fig. 10 Ovalbumin-induced allergic airway disease substantially
modified the lung microbiome. The lung microbiomes of naïve mice
(naïve, n = 56) were compared with those with ovalbumin (OVA)-
induced allergic airway disease (OVA, n = 68), 24 h after respiratory
challenge with OVA, with results combined for all naïve or all OVA
mice. To induce allergic airway disease, mice were injected with OVA
and Alum at 12 weeks of age, boosted with OVA and Alum at
14 weeks of age, and then administered a respiratory challenge with
OVA at 15 weeks of age. Lungs were obtained 24 h later. In (a), a non-
metric multidimensional scaling (NMDS) plot depicts the dissimilarity
of the detected lung of operational taxonomic units (OTUs) for all
mice, and in (b) for mice only fed the vitamin D-supplemented
diet (+). (M = male, F = female; n = 9–10/treatment)
Table 2 Group comparison of the lung microbiomes of naïve
mice, with those from mice with OVA-induced allergic airway
disease within treatments for analysis of similarity (ANOSIM)
Factor Groups ANOSIM R p-value
OVA-induced allergic airway disease M+ 0.434 0.001*
M− 0.394 0.001*
M−/+ 0.354 0.001*
F+ 0.243 0.002*
F− 0.281 0.001*
F−/+ 0.31 0.001*
*Significant clustering, p < 0.05
F = Female
M =Male
(+) = fed vitamin D-supplemented diet throughout life
(−) = fed vitamin D-null diet throughout life
(−/+) = fed vitamin D-null diet until 8 weeks of age and then vitamin
D-supplemented diet
Table 3 Comparison of the lung microbiomes of mice with
OVA-induced allergic airway disease with analysis of similarity
(ANOSIM) examining the effects of sex or dietary vitamin D
Factor Groups compared ANOSIM R p-value
Sex F+ vs M+ 0.149 0.009*
F− vs M− 0.067 0.137
F−/+ vs M−/+ −0.001 0.481
Vitamin D M+ vs M− 0.008 0.418
M+ vs M−/+ 0.028 0.228
M−/+ vs M− 0.076 0.115
F+ vs F− 0.057 0.141
F+ vs F−/+ 0.039 0.219
F−/+ vs F− 0.055 0.178
*Significant clustering, p < 0.05
F = Female
M =Male
(+) = fed vitamin D-supplemented diet throughout life
(−) = fed vitamin D-null diet throughout life
(−/+) = fed vitamin D-null diet until 8 weeks of age and then vitamin
D-supplemented diet
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pathogen-free mice, limiting possible contamination
from the upper respiratory tract and oral cavity. It is
possible that the modest effects of dietary vitamin D
were due to the scarcity of the collected DNA. However,
we believe this is not likely, due to the rigorous use of
negative controls to identify OTUs of contaminating
bacteria [33], our observations of association between
circulating 25(OH)D levels and lung OTUs, and the sig-
nificant microbial shift induced by the induction of aller-
gic airway disease.
a
b
Fig. 11 Ovalbumin-induced allergic airway disease substantially modified the lung microbiome. The lung microbiomes of naïve mice (naïve,
n = 56) were compared with those with ovalbumin (OVA)-induced allergic airway disease (OVA, n = 68), 24 h after respiratory challenge with
OVA, with results combined for all naïve or all OVA mice. To induce allergic airway disease, mice were injected with OVA and Alum at 12 weeks of age,
boosted with OVA and Alum at 14 weeks of age, and then administered a respiratory challenge with OVA at 15 weeks of age. Lungs were obtained
24 h later. In (a), a heat map shows OTUs significantly detected in the lungs of naïve and OVA-sensitised and -challenged mice. OTU counts were log-
transformed; with red denoting increased frequency of a given OTU, and dark blue no occurrence. In (b), a heat map compares the sex-specific
differences in detected Pseudomonas and Acinetobacter OTUs in naïve mice and mice with OVA-induced allergic airway disease (M =male, F =
female), with a significant difference (*p < 0.05) denoting significant more of the most abundant Acinetobacter OTU in male mice with OVA-
induced allergic airway disease (for mice fed a vitamin D-containing diet throughout the experiment)
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Fig. 12 (See legend on next page.)
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Methodological considerations are important, as we
have previously shown differences in the microbial di-
versity of BALF and lung tissue [17]. With the small
biomass of bacteria expected in the lungs of specific-
pathogen-free naïve mice [58], there could also be
problems associated with low yield DNA introduced
through bacterial contamination of commercially pur-
chased products (eg. in molecular-grade water or PCR
reagents, [34]). As described by Salter et al. [34], re-
agents and extractions kits used for 16S amplicon li-
brary preparation can mask real biological effects and
or increase false results. This is particularly a problem
with lung samples as the bacterial yield is low, There-
fore we analyzed data both with and without OTUs
considered as contamination by sequences at low
levels in our negative controls, allowing us to observe
the sex-specific differences in mice fed only a diet
containing vitamin D.
A limitation of the current study was that the naïve
mice did not receive a placebo treatment (i.e. Alum bolus
and nebulisation). We also did not examine the micro-
biome of other locations including the BALF [15, 17], or
the oro- [59] or naso-pharynx [60], which could limit
comparisons with human studies. We could not discern
cause and effect in our modeling: for example, with aller-
gic airway disease did the induced inflammation change
the microbiome (or vice versa)? A detailed time-course
analysis and use of further control groups (i.e. Alum only)
could help determine the cause and effect relationships in
future studies.
Another consideration is the model of asthma used.
This well-characterised model [61] involved sensitisation
of mice with a ‘low dose’ of the allergen OVA (1 μg) with
Alum (0.2 mg), which caused methacholine-induced air-
way hyperresponsiveness, airway eosinophilia and neu-
trophilia, increases in BALF levels of IL-5, and circulating
allergen-specific IgE and IgG [24]. This model induces a
phenotype similar to allergic asthma typified by a T helper
type-2 (Th2) immune response, which is induced by a sin-
gle well-defined allergen [61]. There is no ideal animal
model of allergic asthma [62]; commonly known as aller-
gic airway disease in mice. House dust mite (HDM)
models offer an advantage of using a human allergen;
however, HDM preparations can be contaminated with
varying quantities of bacterial-derived lipopolysaccharide.
The induction of neutrophilic and eosinophilic inflamma-
tion in HDM-induced allergic airway disease models are
dependent on toll-like receptor-4 [63], complicating the
interpretation of the inflammatory response [62], espe-
cially with regards to examining the lung microbiome. We
have shown here that the induction of OVA-induced al-
lergic airway disease significantly altered the lung
microbiome and induced lung inflammation. We hy-
pothesise that factors that modulate airway inflamma-
tion per se, including those induced by other allergens,
such as OVA with Alum or HDM extract [61], will also
modulate the lung microbiome to perpetuate pulmon-
ary inflammation and disease.
In previous studies, we have shown that the effects of
vitamin D deficiency on airway inflammation in male
mice were dependent on the dose of OVA and Alum
used to sensitise mice [24]. However, vitamin D defi-
ciency did not significantly modify airway resistance,
tissue elastance or damping in male mice with OVA-
induced allergic airway disease induced by this low-dose
sensitisation [24]. In other studies we examined the lung
function of naïve vitamin D-deficient and -replete
BALB/c mice and observed increased airway resistance
and tissue damping in female (but not male) vitamin D-
deficient but otherwise naive mice [43]. These observa-
tions suggest that any protective effect of vitamin D on
lung function is limited to female mice, and combined
with a trend for an inverse correlation between total
OTUs in the lungs and serum 25(OH)D levels in female
mice, may suggest that the lung microbiome could regu-
late lung function in a sex-dependent fashion. In
addition, vitamin D may maintain optimal lung function
by preventing airway remodeling through a process
dependent on transforming growth factor-β [43].
In addition to the sex-dependent effects of vitamin D
deficiency on the severity of lung inflammation in mice
with allergic airway disease [24], we have previously
shown that vitamin D deficiency increased the cap-
acity of airway-draining lymph node cells from male
and female mice to proliferate and produce Th2 cyto-
kines [24, 25]. The effects of deficiency were reversed
by subsequent supplementation with dietary vitamin
D3 [24]. Vitamin D deficiency increased the influx of
lymphocytes into BALF in response to exposure to
HDM; however, deficiency was protective and
(See figure on previous page.)
Fig. 12 Allergic airway disease had a substantially greater effect on bronchoalveolar lavage neutrophil numbers than vitamin D deficiency. Neutrophil
and macrophage numbers in the bronchoalveolar lavage (BALF) and blood of naïve mice fed a vitamin D (VitD)-replete (+) or -deficient (−) or initially
vitamin D-deficient then replete diet (−/+) diet were compared with those of vitamin D-replete mice with OVA-induced allergic airway disease, 24 h
after respiratory challenge with OVA. For OVA-sensitisation, mice were injected with OVA and Alum at 12 weeks of age, boosted with OVA and Alum
at 14 weeks of age, and then administered a respiratory challenge with OVA at 15 weeks of age. BALF or blood was obtained 24 h later. In (a-d) results
from males, and (e-h) results from female mice. In (a) and (e) neutrophils, and (b) and (f) macrophages in BALF are shown (n≥ 14 mice/treatment). In
(c) and (g) neutrophils, and (d) and (h) monocytes per ml of blood are depicted (n = 5–10 mice/treatment). Data is shown as mean + SEM (*p < 0.05)
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reduced airway smooth muscle mass and airway re-
sistance induced by HDM [65]. Increased OVA-
specific IgE and IgG1 were detected in vitamin D-
deficient female BALB/c mice following OVA/Alum
sensitisation (without further respiratory challenge)
[66]. Increased lung eosinophil numbers and CD4 +
T1ST2+ cells (Th2 cells), and reduced CD4 + IL-10+
(regulatory) cells were observed in young adult off-
spring born to vitamin D-deficient BALB/c dams fol-
lowing chronic intranasal instillation of HDM to
offspring from 3 days of age [67]. However, as ob-
served in our studies with OVA-induced allergic air-
way disease, there was no effect of vitamin D
deficiency on airway hyperresponsiveness [67]. Col-
lectively, these studies suggest that vitamin D defi-
ciency promotes Th2 responses and the accumulation
of eosinophils and neutrophils in the lungs of mice
with allergic airway disease, without further com-
promising lung function.
We detected a significant negative relationship be-
tween circulating 25(OH)D and total OTUs detected in
the lungs, suggestive of reduced bacterial diversity with
increasing serum 25(OH)D. Others have noted that bac-
terial diversity is increased in healthy lungs when com-
pared to diseased lungs [23]. Patients with poorly
controlled asthma (n = 30) had reduced bacterial diver-
sity and species richness, with increased Haemophilus
influenzae in sputum samples, particularly in younger
males with increased neutrophils (n = 7) [23]. Changes in
bacterial diversity were associated with oral corticoster-
oid intake, airway obstruction, and eosinophilia in lung
lavage fluid [21]. Conversely, bacterial diversity in
bronchial epithelial brushings was positively correlated
with bronchial hyperresponsiveness of adults with sub-
optimally controlled asthma (n = 65) [19]. However,
those with increased baseline diversity had greater im-
provements in bronchial hyperresponsiveness in re-
sponse to clathriomycin treatment [19].
Conclusion
In these studies the capacity of OVA-induced allergic
airway disease to modulate the lung microbiome and in-
duce respiratory inflammation far exceeded any more
subtle effects of vitamin D. We also show that the lung
microbiome is differentially modified by sex in mice fed
a vitamin D-containing diet, through specific effects on
Acinetobacter OTU. It would be interesting to investi-
gate the influence of other dietary or environmental
modifiers on the lung microbiome, such as dietary fibre
and dust from houses with dogs, which both change the
gut microbiome, and have protective effects on the ex-
pression of allergic airway disease in mice [64, 68]. We
identified a negative association between circulating
25(OH)D and OTUs of an unidentified Pseudomonas,
which could be most clinically relevant for patients
where Pseudomonas plays a central role in disease pro-
gression, such as for those with cystic fibrosis or COPD
[69], and suggest that vitamin D status (or circulating
25(OH)D) may reduce the presence of pathobionts in the
lungs. However, further studies in humans are required to
reproduce the preclinical findings reported here.
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